Intra Cellular Therapies | Stammkapital

Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 16K 0 2023-12
ALKERMES USD 1.72M 2K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Cytokinetics USD 102K 8K 2023-12
Gilead Sciences USD 1000K 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Intra Cellular Therapies USD 10K 0 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
RedHill Biopharma USD 4.62M 1.78M 2023-06
Supernus Pharmaceuticals USD 55K 0 2023-12
United Therapeutics USD 700K 0 2023-12



Intra Cellular Therapies Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.